IGF2 loss of imprinting enhances colorectal cancer stem cells pluripotency by promoting tumor autophagy

Tianyi Gao,Xiangxiang Liu,Bangshun He,Yuqin Pan,Shukui Wang

DOI: https://doi.org/10.21203/rs.3.rs-23694/v1

2020-04-24

Abstract:Abstract Background Cancer stem cells (CSCs) are believed to be the driving force behind the tumor growth. So we conducted an in depth study to explore the role of IGF2 epigenetic on CRC stem cells pluripotency aiming to boarder our understanding of the mechanism on CSCs formation. Methods IGF2 imprint status was detected by PCR-RFLP and bisulfite sequencing. Flow cytometry analysis, Immunofluorescence(IF) and sphere-formation assay were performed to investigate the correlation between IGF2 LOI and CSCs. IF and mRFP-eGFP-LC3 fluorescence assay were further used to confirm IGF2 regulation in CSCs autophagy. Finally, RNA interference and CO-IP were conducted in vivo and vitro and the related factors involved were detected by western-blot/real-time PCR. Results The results showed that IGF2 LOI CRC cells usually had a higher CD133 expression and sphere forming efficiency than MOI cells. Then IGF2 LOI CSCs were also found to have a higher autophagy than MOI CSCs which further affect CSCs sphere forming efficiency. Moreover, IGF2/IR-A signal was determined to play a more important role in CSCs formation than IGF2/IGF1R. At last, by using miRNA-195 mimics, we fortunately found the up-regulated IR-A expression might be due to the degradation of miRNA-195 in CRC. Conclusion our results suggested IGF2 LOI promoted CRC stem cells pluripotency by promoting CSCs autophagy. For the degradation of miRNA-195, IGF2 showed a higher ability in interacting with overexpressed IR-A rather than IGF1R which would further modulate CSCs autophagy. All these findings might provide a novel mechanistic insight into the CRC diagnosis and treatment.